Idiopathic macular hole surgery

Objective: To evaluate the anatomic and visual outcomes of patients treated with vitrectomy and preservative free triamcinolone-assisted internal limiting membrane peeling for idiopathic macular hole. Methods: We carried out a retrospective chart review of idiopathic macular hole and divided patients into two groups. Group 1 included eyes that were symptomatic for less than 6 months (acute) and group 2 included eyes with chronic symptoms (> 6 months). All surgeries involved triamcinolone-assisted internal limiting membrane peeling. All patients had a 12-month clinical post operative follow-up period. Main outcome measures included anatomic macular hole closure, visual acuity, and surgical complications. Results: Thirty eight eyes of thirty eight patients were included, 21 in group 1 and 17 in group 2. Anatomic closure was achieved in 38 eyes (100%), with a statistically significant difference in pre and post-operative visual acuity in both groups. Conclusions: Internal limiting membrane peeling assisted with preservative free triamcinolone acetonide is safe and provides excellent anatomic and functional outcomes in eve surgery for acute or chronic idiopathic macular hole. The use of triamcinolone acetonide did not show adverse effects in macular hole closure.